Holen Sie sich die Stockscreener-App
0.0084
46.58%
-0.0011
Vorhandelsmarkt:
.01
0.0016
+19.05%
Schlusskurs vom Vortag:
$0.0095
Offen:
$0.0051
24-Stunden-Volumen:
127.27M
Relative Volume:
71.57
Marktkapitalisierung:
$N/A
Einnahmen:
$14,300
Nettoeinkommen (Verlust:
$-53.02M
KGV:
-0.000000
EPS:
-204009.5226
Netto-Cashflow:
$-18.58M
1W Leistung:
-46.58%
1M Leistung:
-95.51%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.0043
$0.0098
1-Wochen-Bereich:
$0.0043
$0.0098
52-Wochen-Spanne:
$0.0043
$0.0098
Aditxt Inc Stock (ADTX) Company Profile
Compare ADTX vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADTX
Aditxt Inc
|
0.0084 | 0 | 14,300 | -53.02M | -18.58M | -204,009.52 |
VRTX
Vertex Pharmaceuticals Inc
|
547.59 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
828.50 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,011.11 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.89 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.58 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Aditxt Inc Aktie (ADTX) Neueste Nachrichten
ORCL Stock Tumbles 10% Despite Earnings Beat, But Wall Street Recommends 'Aggressive' Buying On Selloff - Stocktwits
ADTX Stock Surges 40% Overnight: New 10% Holder Emerges After Aditxt’s Ignite Proteomics SPAC Deal - Stocktwits
Aditxt Company Profile & Introduction - Moomoo
ADTX Stock Rockets 90% Premarket: What's Fueling Rebound After A Record 22-Day Selloff? - Stocktwits
Aditxt sells Pearsanta subsidiary, keeps up to $2.5M royalty upside - Dealroom
ADTX Stock Crashes Over 20% After Third Reverse Split In 7 Months – Retail Calls The Decline ‘Unreasonable’ - Stocktwits
Aditxt completes sale of Pearsanta subsidiary, retains up to $2.5M royalty stream - Minichart
Form 8K Aditx Therapeutics Inc For: 19 August By Investing.com - Investing.com South Africa
Aditxt sells majority-owned Pearsanta; retains royalties, milestone payments - TradingView
Aditxt (NASDAQ: ADTX) exits Pearsanta but keeps slice of future sales - Stock Titan
Aditxt Inc (ADTX) Performance - The Globe and Mail
Aditxt (ADTX) Quarter in Focus: The Company Releases Its Current Earnings Data in the Latest Session ; Share-Price Response Remains UnconfirmedAnalyst Consensus Shift - dars.gov.et
Aditxt (ADTX) Quarterly Performance Check: The Company Publishes Its Latest Results Reported Without a Verified Price ReactionEarnings Sentiment Score - vinanet.vn
An undisclosed buyer acquired 90.20% stake in Pearsanta, Inc. from Aditxt, Inc.. - marketscreener.com
Why Is ADTX Stock In Spotlight Today? - Stocktwits
ADTX Stock Loses Nasdaq Listing After Seven Reverse Splits Fail To Restore Compliance: Why Is Retail Still Bullish? - Stocktwits
MSN Money - MSN
Aditxt(ADTX) Stock Options Chain | Quotes & News - Moomoo
Aditxt amends note agreement, expands secured financing - The Globe and Mail
Aditxt Amends Note Purchase Pact to Add Investor, Swap Notes With No Change in Principal - TradingView
Aditxt (NASDAQ: ADTX) revises note deal, issues more secured notes - Stock Titan
Wey Ann Tai Net Worth (2026) - GuruFocus
ADTX Q3 2025 Earnings: Deep Losses Persist as Pre-Revenue Biotech Navigates Cash ConstraintsNon-GAAP Earnings - dars.gov.et
Finanzdaten der Aditxt Inc-Aktie (ADTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
3.22%
Kapitalisierung:
|
Volumen (24h):